🇸🇬 Fabhalta in Singapore

Fabhalta (IPTACOPAN) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Fabhalta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Singapore

Frequently asked questions

Is Fabhalta approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Fabhalta in Singapore?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.